Marshall Wace
SHC icon

Marshall Wace’s Sotera Health SHC Stock Holding History

Marshall Wace’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.69M Buy
327,298
+87,128
+36% +$1.45M ﹤0.01% 1340
2025
Q4 		$4.24M Buy
+240,170
New +$3.97M ﹤0.01% 1227
2025
Q2 		– Sell
-164,786
Closed -$1.92M – 3117
2025
Q1 		$1.92M Buy
+164,786
New +$2.12M ﹤0.01% 1483
2024
Q4 		– Sell
-19,988
Closed -$334K – 2962
2024
Q3 		$334K Sell
19,988
-12,708
-39% -$186K ﹤0.01% 2088
2024
Q2 		$388K Buy
32,696
+7,955
+32% +$90.8K ﹤0.01% 2058
2024
Q1 		$297K Buy
+24,741
New +$368K ﹤0.01% 2117
2023
Q4 		– Sell
-147,263
Closed -$2.21M – 2571
2023
Q3 		$2.21M Sell
147,263
-201,070
-58% -$3.39M ﹤0.01% 1180
2023
Q2 		$6.56M Buy
348,333
+231,736
+199% +$3.68M 0.01% 911
2023
Q1 		$2.09M Buy
+116,597
New +$1.95M ﹤0.01% 1434
2022
Q4 		– Sell
-845,356
Closed -$5.76M – 3372
2022
Q3 		$5.76M Buy
+845,356
New +$14.1M 0.01% 1269
2022
Q1 		– Sell
-9,155
Closed -$216K – 3949
2021
Q4 		$216K Buy
+9,155
New +$219K ﹤0.01% 3137
2021
Q2 		– Sell
-184,867
Closed -$4.61M – 3039
2021
Q1 		$4.61M Buy
184,867
+144,120
+354% +$3.81M 0.02% 884
2020
Q4 		$1.12M Buy
+40,747
New +$1.09M 0.01% 1166

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Marshall Wace's SHC Position: Q1 2026 in Review

Marshall Wace increased its Sotera Health (SHC) stake by 36% in Q1 2026, buying an estimated $1.45M and bringing the position to 327,298 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1340.

Marshall Wace first reported a position in SHC in Q4 2020 and has held it in 13 quarters since. The position peaked at $6.56M in Q2 2023. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Marshall Wace held 327,298 shares of Sotera Health worth $4.69M as of Q1 2026.
  • Marshall Wace bought 87,128 Sotera Health shares in Q1 2026, an estimated $1.45M.
  • Sotera Health made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1340 holding.
  • Marshall Wace first reported a position in Sotera Health in Q4 2020 and has held it in 13 quarters since.
  • Marshall Wace's Sotera Health position peaked at $6.56M in Q2 2023.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.